GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 133 filers reported holding GENOMIC HEALTH INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $20,556,000 | +9.7% | 699,415 | +8.0% | 0.00% | 0.0% |
Q3 2016 | $18,730,000 | +23.9% | 647,646 | +10.9% | 0.00% | +50.0% |
Q2 2016 | $15,116,000 | +15.6% | 583,742 | +10.5% | 0.00% | 0.0% |
Q1 2016 | $13,081,000 | -33.9% | 528,113 | -6.1% | 0.00% | -33.3% |
Q4 2015 | $19,791,000 | +59.1% | 562,234 | -4.4% | 0.00% | +50.0% |
Q3 2015 | $12,441,000 | -28.7% | 587,927 | -6.3% | 0.00% | -33.3% |
Q2 2015 | $17,439,000 | +2.4% | 627,528 | +12.6% | 0.00% | 0.0% |
Q1 2015 | $17,022,000 | -4.4% | 557,178 | +0.0% | 0.00% | 0.0% |
Q4 2014 | $17,811,000 | +13.5% | 557,114 | +0.5% | 0.00% | 0.0% |
Q3 2014 | $15,688,000 | +1.8% | 554,141 | -1.5% | 0.00% | 0.0% |
Q2 2014 | $15,408,000 | +3.4% | 562,336 | -0.6% | 0.00% | 0.0% |
Q1 2014 | $14,902,000 | -6.1% | 565,755 | +4.3% | 0.00% | 0.0% |
Q4 2013 | $15,871,000 | +1.7% | 542,240 | +6.2% | 0.00% | 0.0% |
Q3 2013 | $15,607,000 | -5.5% | 510,364 | -2.0% | 0.00% | 0.0% |
Q2 2013 | $16,521,000 | – | 521,017 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |